Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biologic therapy.

H Edington1, S Agarwala, J M Kirkwood

  • 1Division of Plastic and Reconstructive Surgery, Magee Womens Hospital, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pennsylvania 15213, USA.

Clinics in Plastic Surgery
|October 20, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-year survival with tebentafusp in metastatic uveal melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis.

Immuno-oncology technology·2025
Same author

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Accuracy of a convolutional neural network for dermatological diagnosis of tumours and skin lesions in a clinical setting.

Clinical and experimental dermatology·2021
Same author

Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Schilling et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Biologic therapy is a new fourth-line treatment for melanoma and other cancers. Advances in molecular diagnostics and gene therapy will speed up progress in this field.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Biologic therapy has emerged as a significant advancement in cancer treatment.
  • It represents the fourth major treatment modality alongside surgery, radiation, and chemotherapy.
  • High-risk melanoma patients have a growing number of therapeutic choices.

Purpose of the Study:

  • To review the current landscape of biologic therapeutic options for patients with high-risk melanoma.
  • To highlight the impact of molecular diagnostics and gene therapy on the evolution of biologic treatments.

Main Methods:

  • Literature review of current biologic therapies for melanoma.
  • Analysis of recent advances in molecular diagnostics and gene therapy relevant to oncology.

Related Experiment Videos

Main Results:

  • Biologic therapy is a rapidly evolving field with increasing efficacy.
  • Integration of molecular diagnostics and gene therapy promises further breakthroughs.
  • A range of biologic options are becoming available for high-risk melanoma patients.

Conclusions:

  • Biologic therapy is a crucial fourth treatment option for melanoma and other malignancies.
  • Continued research in molecular diagnostics and gene therapy will drive future therapeutic innovations.
  • Patients with high-risk melanoma benefit from a diverse and expanding array of biologic treatments.